F
Fennec Pharmaceuticals Inc. Common StockFENC
Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Fennec is focused on the commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in cancer.
US StocksBiotechnologyHealthcareSmall Cap
FENC Price Trend
Fennec Pharmaceuticals Inc. Common Stock · Full TradingView Chart
NASDAQ:FENC